These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
837 related items for PubMed ID: 8895571
21. Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast. Alarcon CM, Heitman J, Cardenas ME. Mol Biol Cell; 1999 Aug; 10(8):2531-46. PubMed ID: 10436010 [Abstract] [Full Text] [Related]
22. Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. Shegogue D, Trojanowska M. J Biol Chem; 2004 May 28; 279(22):23166-75. PubMed ID: 15047702 [Abstract] [Full Text] [Related]
23. Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells. Quevedo C, Salinas M, Alcázar A. Biochem Biophys Res Commun; 2002 Mar 01; 291(3):560-6. PubMed ID: 11855825 [Abstract] [Full Text] [Related]
24. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function. Li SY, Fang CX, Aberle NS, Ren BH, Ceylan-Isik AF, Ren J. J Endocrinol; 2005 Sep 01; 186(3):491-503. PubMed ID: 16135669 [Abstract] [Full Text] [Related]
25. CD137 ligand-mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: involvement of mTOR/p70S6 kinase and Akt. Kim DK, Lee SC, Lee HW. Eur J Immunol; 2009 Sep 01; 39(9):2617-28. PubMed ID: 19676073 [Abstract] [Full Text] [Related]
26. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Monfar M, Lemon KP, Grammer TC, Cheatham L, Chung J, Vlahos CJ, Blenis J. Mol Cell Biol; 1995 Jan 01; 15(1):326-37. PubMed ID: 7528328 [Abstract] [Full Text] [Related]
27. Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wiederrecht G, Abraham RT. J Biol Chem; 1995 Jan 13; 270(2):815-22. PubMed ID: 7822316 [Abstract] [Full Text] [Related]
28. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL. Clin Cancer Res; 2008 May 01; 14(9):2543-50. PubMed ID: 18451215 [Abstract] [Full Text] [Related]
29. Inhibition of MG-63 cell proliferation and PDGF-stimulated cellular processes by inhibitors of phosphatidylinositol 3-kinase. Thomas JE, Venugopalan M, Galvin R, Wang Y, Bokoch GM, Vlahos CJ. J Cell Biochem; 1997 Feb 01; 64(2):182-95. PubMed ID: 9027579 [Abstract] [Full Text] [Related]
30. The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelárová H, Meijer AJ. Eur J Biochem; 1997 Jan 15; 243(1-2):240-6. PubMed ID: 9030745 [Abstract] [Full Text] [Related]
31. Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells. Diggle TA, Moule SK, Avison MB, Flynn A, Foulstone EJ, Proud CG, Denton RM. Biochem J; 1996 Jun 01; 316 ( Pt 2)(Pt 2):447-53. PubMed ID: 8687386 [Abstract] [Full Text] [Related]
32. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Zhou L, Goldsmith AM, Bentley JK, Jia Y, Rodriguez ML, Abe MK, Fingar DC, Hershenson MB. Am J Respir Cell Mol Biol; 2005 Aug 01; 33(2):195-202. PubMed ID: 15901615 [Abstract] [Full Text] [Related]
33. Interferon alpha-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. Thyrell L, Hjortsberg L, Arulampalam V, Panaretakis T, Uhles S, Dagnell M, Zhivotovsky B, Leibiger I, Grandér D, Pokrovskaja K. J Biol Chem; 2004 Jun 04; 279(23):24152-62. PubMed ID: 15056668 [Abstract] [Full Text] [Related]
34. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Rosenzweig KE, Youmell MB, Palayoor ST, Price BD. Clin Cancer Res; 1997 Jul 04; 3(7):1149-56. PubMed ID: 9815794 [Abstract] [Full Text] [Related]
35. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-gamma is regulated by mammalian target of rapamycin. Kristof AS, Marks-Konczalik J, Billings E, Moss J. J Biol Chem; 2003 Sep 05; 278(36):33637-44. PubMed ID: 12807916 [Abstract] [Full Text] [Related]
36. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J. Genes Dev; 2002 Jun 15; 16(12):1472-87. PubMed ID: 12080086 [Abstract] [Full Text] [Related]
37. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. Párrizas M, Saltiel AR, LeRoith D. J Biol Chem; 1997 Jan 03; 272(1):154-61. PubMed ID: 8995241 [Abstract] [Full Text] [Related]
38. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation. Wang X, Yue P, Chan CB, Ye K, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Fu H, Khuri FR, Sun SY. Mol Cell Biol; 2007 Nov 03; 27(21):7405-13. PubMed ID: 17724079 [Abstract] [Full Text] [Related]
39. Lack of inhibition of phosphoinositide 3-kinase enzyme activity by FKBP12/rapamycin. Hollis CM, Hutchinson R. Biochem Soc Trans; 1996 Feb 03; 24(1):66S. PubMed ID: 8674742 [No Abstract] [Full Text] [Related]
40. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA. J Endocrinol; 2005 May 03; 185(2):275-89. PubMed ID: 15845920 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]